CORE 2021 – On-demand
Published: 16 June 2021
-
Views:
71917
-
Likes:
7
Overview
Full programme
The MDT Discussion – Defining Standards
- Welcome and Angina as a Therapeutic Goal – Redefining Success
- Treating Angina: How to Leverage the Placebo Effect!
- The MDT Discussion – Defining Standards
- LIVE CASES: MVD Case Physiology - Defining Target Lesion, Bystander Disease, and INOCA Patient - How to Perform Full Physiology
- Myocardial Bridge – Physiology and Guide to Assessment and Treatment and Morning Summary
Overview
The 5th annual CORE meeting (16 and 17 June 2021) was hosted by Radcliffe Cardiology in collaboration with Optima Education and Abbott Vascular.
The meeting was led by Course Directors Prof Adrian Banning, Prof Evald Christiansen, Dr Jonathan Hill and Prof James Spratt and streamed from our London, Copenhagen, and Dublin hubs.
CORE 2021 focuses on contemporary standards of clinical practice, complex lesion and patient strategies and advanced diagnostic and treatment methods. The goal of CORE is to ensure procedural efficiencies while achieving durable patient outcomes, review patient care beyond intervention and discuss the best practices and innovation outside the catheterisation lab.
More from this programme
Part 1
CORE 2021 – Day 1: Morning – Physiology
Part 2
CORE 2021 – Day 1: Afternoon – Bifurcation Management
Part 3
CORE 2021 – Day 2: Morning – Durable Outcomes
Part 4
CORE 2021 – Day 2: Afternoon – Beyond Intervention
Faculty Biographies
Sarah Clarke
Consultant Cardiologist, Royal Papworth Hospital, Cambridge
Dr Sarah C Clarke is a Consultant Cardiologist and the Clinical Director for Strategic Development at Royal Papworth Hospital, Cambridge.
Adrian P Banning
Dr Adrian Banning is a consultant cardiologist specialising in percutaneous coronary intervention.
He is the president of the British Cardiac Intervention Society and was previously the Divisional Director for Cardiology, Cardiothoracic and Vascular Surgery at the John Radcliffe University Hospital, Oxford. Through his position at the John Radcliffe, and his own practice at Oxford’s The Manor Hospital, Prof Banning provides specialist regional services for coronary and valvular heart disease patients to an area of 1.2 million people.
Prof Banning is pioneering research in his field and lectures nationally and internationally. He has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.
Rasha Al-Lamee
Interventional Cardiology Consultant
Dr Rasha Al-Lamee is an interventional cardiology consultant at Imperial College Healthcare NHS Trust, London, UK.
Dr Al-Lamee studied at the University of Oxford and University College London. She completed her training in clinical cardiology on the north-west London cardiology rotation in 2013, and completed her PhD at Imperial College London in 2018.
Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is lead author of the primary publication in The Lancet. Dr Al-Lamee has more than 50 peer-reviewed publications and has presented at international cardiology conferences worldwide.
Peter O’Kane
Consultant Interventional Cardiologist
Dr Peter O’Kane was appointed as a consultant interventional cardiologist at Royal Bournemouth Hospital in July 2007 and has performed more than 7000 PCI cases. He has extensive experience with coronary physiology and intra-coronary imaging to guide intervention and the many tools and techniques to manage bifurcations, calcification and chronic occlusions.
He is committed to teaching and has trained many physicians both in UK and Internationally in devices such as Rotational and Laser Atherectomy, technical skills such as those involved in bifurcation stenting and coronary imaging utilisation. He has presented at many Cardiology conferences and performed as a live case operator. He has contributed to 30 global research studies as local principal investigator with high provision of…
Jonathan Hill
Dr Jonathan Hill qualified from Edinburgh University Medical School in 1992 following pre-clinical training at Cambridge University. He trained in cardiology at The London Chest and St Bartholomew's Hospitals.
In 1999 he was awarded the first National Heart, Lung and Blood Institute Bench to Bedside award and trained in basic science and interventional research within the Cardiovascular Branch of the National Institutes of Health in Bethesda. He completed his interventional cardiology training at the London Chest Hospital.
In 2005 he was appointed as Clinical Senior Lecturer and Consultant Cardiologist at King's College London.